TGA grant provisional approval for Pfizer vaccine in 5-11 years

On December 3, 2021, the TGA grant provisionally registration to Pfizer’s COVID-19 paediatric , mRNA technology vaccine for use in 5 to 11 year olds, followed up by ATAGI‘s approval. [1]

This decision follows the provisional approvals granted by the TGA to Pfizer for the use of COMIRNATY in individuals 12 years and older on 22 July 2021 and the booster dose for use in adults 18 years and older on 26 October 2021.